These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22022556)

  • 1. Dtorsin, the Drosophila ortholog of the early-onset dystonia TOR1A (DYT1), plays a novel role in dopamine metabolism.
    Wakabayashi-Ito N; Doherty OM; Moriyama H; Breakefield XO; Gusella JF; O'Donnell JM; Ito N
    PLoS One; 2011; 6(10):e26183. PubMed ID: 22022556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutant human torsinA, responsible for early-onset dystonia, dominantly suppresses GTPCH expression, dopamine levels and locomotion in Drosophila melanogaster.
    Wakabayashi-Ito N; Ajjuri RR; Henderson BW; Doherty OM; Breakefield XO; O'Donnell JM; Ito N
    Biol Open; 2015 Apr; 4(5):585-95. PubMed ID: 25887123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the porcine TOR1A gene: The first step towards generation of a pig model for dystonia.
    Henriksen C; Madsen LB; Bendixen C; Larsen K
    Gene; 2009 Feb; 430(1-2):105-15. PubMed ID: 19028553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional specificity of synaptic plasticity deficits in a knock-in mouse model of DYT1 dystonia.
    Martella G; Maltese M; Nisticò R; Schirinzi T; Madeo G; Sciamanna G; Ponterio G; Tassone A; Mandolesi G; Vanni V; Pignatelli M; Bonsi P; Pisani A
    Neurobiol Dis; 2014 May; 65():124-32. PubMed ID: 24503369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Function of dopamine transporter is compromised in DYT1 transgenic animal model in vivo.
    Hewett J; Johanson P; Sharma N; Standaert D; Balcioglu A
    J Neurochem; 2010 Apr; 113(1):228-35. PubMed ID: 20132487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Torsins Are Essential Regulators of Cellular Lipid Metabolism.
    Grillet M; Dominguez Gonzalez B; Sicart A; Pöttler M; Cascalho A; Billion K; Hernandez Diaz S; Swerts J; Naismith TV; Gounko NV; Verstreken P; Hanson PI; Goodchild RE
    Dev Cell; 2016 Aug; 38(3):235-47. PubMed ID: 27453503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane defects and genetic redundancy: Are we at a turning point for DYT1 dystonia?
    Cascalho A; Jacquemyn J; Goodchild RE
    Mov Disord; 2017 Mar; 32(3):371-381. PubMed ID: 27911022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease Modeling with Human Neurons Reveals LMNB1 Dysregulation Underlying DYT1 Dystonia.
    Ding B; Tang Y; Ma S; Akter M; Liu ML; Zang T; Zhang CL
    J Neurosci; 2021 Mar; 41(9):2024-2038. PubMed ID: 33468570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and characterization of Dyt1 DeltaGAG knock-in mouse as a model for early-onset dystonia.
    Dang MT; Yokoi F; McNaught KS; Jengelley TA; Jackson T; Li J; Li Y
    Exp Neurol; 2005 Dec; 196(2):452-63. PubMed ID: 16242683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The zebrafish homologue of the human DYT1 dystonia gene is widely expressed in CNS neurons but non-essential for early motor system development.
    Sager JJ; Torres GE; Burton EA
    PLoS One; 2012; 7(9):e45175. PubMed ID: 23028827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine release is impaired in a mouse model of DYT1 dystonia.
    Balcioglu A; Kim MO; Sharma N; Cha JH; Breakefield XO; Standaert DG
    J Neurochem; 2007 Aug; 102(3):783-8. PubMed ID: 17550429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebellar synaptogenesis is compromised in mouse models of DYT1 dystonia.
    Vanni V; Puglisi F; Bonsi P; Ponterio G; Maltese M; Pisani A; Mandolesi G
    Exp Neurol; 2015 Sep; 271():457-67. PubMed ID: 26183317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia.
    Napolitano F; Pasqualetti M; Usiello A; Santini E; Pacini G; Sciamanna G; Errico F; Tassone A; Di Dato V; Martella G; Cuomo D; Fisone G; Bernardi G; Mandolesi G; Mercuri NB; Standaert DG; Pisani A
    Neurobiol Dis; 2010 Jun; 38(3):434-45. PubMed ID: 20227500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of Protein Processing in the Endoplasmic Reticulum of DYT1 Knock-in Mice Implicates Novel Pathways in Dystonia Pathogenesis.
    Beauvais G; Bode NM; Watson JL; Wen H; Glenn KA; Kawano H; Harata NC; Ehrlich ME; Gonzalez-Alegre P
    J Neurosci; 2016 Oct; 36(40):10245-10256. PubMed ID: 27707963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal motor function and dopamine neurotransmission in DYT1 DeltaGAG transgenic mice.
    Zhao Y; DeCuypere M; LeDoux MS
    Exp Neurol; 2008 Apr; 210(2):719-30. PubMed ID: 18299128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional evidence implicating a novel TOR1A mutation in idiopathic, late-onset focal dystonia.
    Calakos N; Patel VD; Gottron M; Wang G; Tran-Viet KN; Brewington D; Beyer JL; Steffens DC; Krishnan RR; Züchner S
    J Med Genet; 2010 Sep; 47(9):646-50. PubMed ID: 19955557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of patient-specific induced pluripotent stem cell line (CSUi002-A) from a patient with isolated dystonia carrying TOR1A mutation.
    Wu J; Ren J; Luo H; Zuo X; Tang Y
    Stem Cell Res; 2021 May; 53():102277. PubMed ID: 33706202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinergic dysregulation produced by selective inactivation of the dystonia-associated protein torsinA.
    Sciamanna G; Hollis R; Ball C; Martella G; Tassone A; Marshall A; Parsons D; Li X; Yokoi F; Zhang L; Li Y; Pisani A; Standaert DG
    Neurobiol Dis; 2012 Sep; 47(3):416-27. PubMed ID: 22579992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tor1a+/- mice develop dystonia-like movements via a striatal dopaminergic dysregulation triggered by peripheral nerve injury.
    Ip CW; Isaias IU; Kusche-Tekin BB; Klein D; Groh J; O'Leary A; Knorr S; Higuchi T; Koprich JB; Brotchie JM; Toyka KV; Reif A; Volkmann J
    Acta Neuropathol Commun; 2016 Oct; 4(1):108. PubMed ID: 27716431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling cellular phenotypes of novel TorsinA/TOR1A mutations.
    Vulinovic F; Lohmann K; Rakovic A; Capetian P; Alvarez-Fischer D; Schmidt A; Weißbach A; Erogullari A; Kaiser FJ; Wiegers K; Ferbert A; Rolfs A; Klein C; Seibler P
    Hum Mutat; 2014 Sep; 35(9):1114-22. PubMed ID: 24931141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.